After Subrahmanian’s departure, effective Dec. 31, he’s slated to stay on until March 31, 2016, as an advisor, Stryker said in a regulatory filing.
International sales were down across the board during Stryker’s 2nd quarter, slumping -9.8% to $716 million for the 3 months ended June 30. Due to the strong dollar, however, constant-currency growth was 4.1%, with orthopedic implant constant-currency sales up 3.0% to $ 1.04 billion, compared with Q2 2014.
Accuray promotes finance SVP Waters to replace retiring CFO Lichtwardt
Accuray (NSDQ:ARAY) promoted finance senior vice president Kevin Waters to CFO effective Sept. 15, replacing finance chief Gregory Lichtwaldt, who retired as executive VP of operations as well.
VC shop PureTech taps Iron Mountain exec MacLean for CFO
PureTech Health (LSE:PRTC) said it tapped the former finance chief for Iron Mountain (NYSE:IRM), Michael MacLean, to be its new CFO.
Ellipse grabs ex-NuVasive, Endologix execs
Ellipse Technologies said it named former NuVasive (NSDQ:NUVA) global sales president Jeff Rydin chief sales officer and Bob Krist, former CFO at Endologix (NSDQ:ELGX), as CFO.